Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02508467 |
|---|---|
| Brief Title: | A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma |
| First Submitted : | July 9, 2015 |
| First Submitted that Met QC Criteria : | July 23, 2015 |
| First Posted : | July 27, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 12, 2022 |
| Last Update Posted : | August 15, 2022 |